List of companies in 3E Bioventures Capital (3E)'s investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer. | ||||||
Cytek Biosciences is a developer and supplier of high-precision research programs that help scientists study human body cells. | ||||||
Dewpoint Therapeutics is a US-based drug manufacturing company. | ||||||
Biocytogen is a biotechnology company headquartered in Beijing developing antibody drug discovery solutions based on gene editing and animal model studies. | ||||||
Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer. | ||||||
Profusa, Inc. is a company that works in the health care sector. | ||||||
Subtle Medical is a medical imaging software company based in Menlo Park, CA. | ||||||
Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs. | ||||||
Cardea Bio is a San Diego-based company developing biology-gated transistors for molecular diagnostics. | ||||||
A biopharmaceutical company developing antibodies for cancer, inflammatory diseases and ophthalmic diseases | ||||||
EpimAb Biotherapeutics is a bi-specific Antibodies founded in 2015 by Chengbin Wu. | ||||||
UltraClear Laser, developed by Acclaro Medical, is a pioneering provider of advanced laser systems for skin rejuvenation. Their flagship product, the UltraClear® Cold Fiber Laser, integrates cutting-edge technologies to offer effective treatments for various skin conditions with minimal discomfort and downtime. | ||||||
UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types. | ||||||
Anti-virals | ||||||
CytoNiche is a Beijing-based company founded in 2018. | ||||||
Doctor Shaoyang is a Guangzhou-based healthcare company founded in 2015 by Zhaoyu Lin. | ||||||
Arnatar Therapeutics Inc. is a San Diego-based biotechnology company founded in 2021 by Dr. Xuehai Liang and Dr. Yanfeng Wang. The company specializes in developing RNA-based therapies using its proprietary DARGER™ platform, which combines gene silencing with the ability to upregulate protein expression. |
